Ghrelin: What This Appetite Hormone Test Actually Measures

Medical lab testing image for Ghrelin: What This Appetite Hormone Test Actually Measures

At a glance

  • Hormone source / Produced mainly by oxyntic glands in the gastric fundus
  • Active form / Acylated (octanoylated) ghrelin, modified by the enzyme GOAT
  • Fasting reference range / 300 to 700 pg/mL for total ghrelin (lab-specific; always confirm with your testing facility)
  • Peak timing / Ghrelin surges 1 to 2 hours before habitual meal times
  • Post-meal nadir / Levels drop 50 to 60% within 30 to 60 minutes of eating
  • GLP-1 connection / Semaglutide and tirzepatide significantly suppress ghrelin-driven hunger signaling
  • Sample handling / Requires aprotinin-treated (protease inhibitor) tube and immediate cold centrifugation
  • Clinical use / Prader-Willi syndrome, post-bariatric surgery monitoring, cachexia workup, appetite dysregulation

What Ghrelin Is and Why It Matters

Ghrelin is a 28-amino-acid peptide hormone identified in 1999 by Kojima et al. At Kurume University. It functions as the body's primary orexigenic (appetite-stimulating) signal, acting on growth hormone secretagogue receptors (GHS-R1a) in the hypothalamus and brainstem 1. No other circulating hormone has a stronger meal-initiation effect.

Where Ghrelin Comes From

About 60 to 70% of circulating ghrelin originates from X/A-like enteroendocrine cells in the gastric fundus 2. Smaller amounts are produced in the duodenum, pancreas, and hypothalamus. The enzyme ghrelin O-acyltransferase (GOAT) attaches an octanoyl group to the serine-3 residue, converting inactive des-acyl ghrelin into biologically active acylated ghrelin. Only the acylated form binds the GHS-R1a receptor and triggers hunger.

Two Forms, Two Functions

A ghrelin test can measure total ghrelin (acylated plus des-acyl), acylated ghrelin alone, or des-acyl ghrelin alone. Acylated ghrelin represents only 10 to 20% of total circulating ghrelin but carries nearly all the appetite-stimulating activity 3. Des-acyl ghrelin, once thought to be inert, appears to have independent metabolic effects, including improved insulin sensitivity in some preclinical models. Ordering the right fraction matters: if the clinical question is about hunger drive, acylated ghrelin is the more informative analyte.

How Ghrelin Behaves in the Body

Ghrelin follows a predictable circadian and meal-driven rhythm. Levels spike before anticipated meals and fall sharply after food intake, making it the only known gut hormone that increases before eating rather than after.

The Pre-Meal Surge

Fasting ghrelin concentrations typically peak in the late morning if breakfast is skipped. A 2007 study in the American Journal of Physiology documented that ghrelin levels in lean subjects rose by an average of 78% above nadir in the 1 to 2 hours preceding a habitual lunch 4. This surge activates hypothalamic neuropeptide Y (NPY) and agouti-related peptide (AgRP) neurons, the same circuits targeted by many anti-obesity pharmacotherapies.

The Post-Meal Suppression

Macronutrient composition affects how quickly ghrelin drops after a meal. Protein produces the most sustained suppression, carbohydrates cause a rapid but short-lived dip, and fat generates an intermediate response 5. A mixed meal in healthy adults reduces ghrelin by roughly 50 to 60% within 30 minutes. Failure of this postprandial suppression is one hallmark of Prader-Willi syndrome.

Growth Hormone Release

Ghrelin was originally discovered as an endogenous ligand for the growth hormone secretagogue receptor. Intravenous ghrelin administration causes a dose-dependent rise in growth hormone (GH), with peak GH levels occurring 15 to 30 minutes after infusion. This pathway explains why ghrelin testing sometimes appears in growth-hormone-deficiency workups, although the GH stimulation test using synthetic GH-releasing peptides remains the clinical standard.

Normal Ghrelin Levels: Reference Ranges

Reference ranges for ghrelin vary significantly depending on the assay methodology, the form measured, and sample handling. There is no universally standardized ghrelin reference interval endorsed by the Endocrine Society, which makes proper specimen collection and lab-specific norms critical.

Commonly Cited Ranges

Total ghrelin in fasting adults generally falls between 300 and 700 pg/mL using radioimmunoassay (RIA) or enzyme-linked immunosorbent assay (ELISA) platforms 6. Acylated ghrelin, when measured separately, typically ranges from 30 to 120 pg/mL in the fasting state. These numbers should be interpreted alongside the patient's BMI, recent food intake, and medication history.

Factors That Shift Ghrelin

Body composition is the strongest non-dietary determinant. Individuals with obesity tend to have lower fasting ghrelin levels than lean individuals, a finding confirmed in a meta-analysis of 14 studies (pooled N=1,280) published in Obesity Reviews 7. After diet-induced weight loss, ghrelin rises. This rebound is one proposed driver of post-diet weight regain: a 2011 New England Journal of Medicine study (N=50) showed that ghrelin increased by 20% after a 10-week very-low-calorie diet and remained elevated at 62 weeks 8.

Age, sex, and sleep also affect levels. Women tend to have higher circulating ghrelin than men at the same BMI. Sleep deprivation (fewer than 5 hours) raised ghrelin by 14.9% in a crossover study of 12 healthy men 9.

What High Ghrelin Means Clinically

Elevated ghrelin (above the upper limit of the lab's reference range) signals that the body is generating a stronger-than-expected hunger drive. Several conditions produce this pattern.

Prader-Willi Syndrome

Prader-Willi syndrome (PWS) is the most studied high-ghrelin condition. Fasting ghrelin levels in PWS patients are 3 to 4 times higher than BMI-matched controls 10. This persistent hyperghrelinemia contributes to the hyperphagia that defines the disorder. Ghrelin testing can help differentiate early PWS from other causes of childhood obesity when genetic testing is pending.

Post-Diet Weight Loss

As noted above, caloric restriction and significant weight loss reliably increase ghrelin. The NEJM study by Sumithran et al. Demonstrated that this hormonal rebound persists for at least a year, contributing to the biological drive to regain lost weight 8. This finding has shaped how clinicians counsel patients about long-term weight maintenance after lifestyle interventions.

Anorexia Nervosa and Cachexia

Ghrelin is elevated in anorexia nervosa (as a compensatory response to chronic energy deficit) and in cancer-associated cachexia. In a study of 20 women with anorexia nervosa, mean fasting ghrelin was 1,140 pg/mL vs. 580 pg/mL in healthy controls 11. Paradoxically, the appetite-stimulating effect of this elevated ghrelin appears blunted in anorexia, suggesting downstream receptor desensitization or competing neural signals.

What Low Ghrelin Means Clinically

Below-range ghrelin is less commonly tested for but carries its own clinical significance.

After Bariatric Surgery

Sleeve gastrectomy removes a large portion of the gastric fundus, the primary ghrelin-producing tissue. Post-sleeve ghrelin levels fall by 60 to 70% and remain suppressed for at least 5 years in most patients 12. This sustained suppression is considered one mechanism (alongside GLP-1 changes and bile acid shifts) through which the sleeve achieves durable weight loss. Roux-en-Y gastric bypass produces a more variable ghrelin response; some studies show a decrease, others show no change.

Obesity Without Intervention

Paradoxically, basal ghrelin tends to be lower in individuals with higher BMI. This does not mean these patients lack hunger. The current hypothesis, supported by data from the Framingham Heart Study Offspring cohort, is that ghrelin sensitivity (rather than ghrelin quantity) may be altered in obesity 13.

Short Bowel Syndrome

Patients with extensive small bowel resection or those receiving long-term parenteral nutrition may exhibit suppressed ghrelin due to altered enteroendocrine signaling, though data in this population remain limited.

Ghrelin and GLP-1 Receptor Agonist Therapy

The relationship between ghrelin and GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) is one of the most clinically relevant reasons to understand this hormone.

How GLP-1 Drugs Suppress Ghrelin Signaling

GLP-1 and ghrelin occupy opposing arms of the appetite circuit. GLP-1 receptor agonists reduce food intake through multiple mechanisms: slowing gastric emptying, activating brainstem satiety centers, and suppressing the pre-meal ghrelin surge. A 2014 study in Diabetes Care showed that liraglutide 1.8 mg daily reduced post-meal acylated ghrelin by 19% compared to placebo over 14 weeks 14. The Endocrine Society's 2024 clinical practice guideline on pharmacological management of obesity recognizes GLP-1 receptor agonists as first-line pharmacotherapy for adults with BMI ≥30 or BMI ≥27 with comorbidities 15.

Monitoring Ghrelin on GLP-1 Therapy

Routine ghrelin monitoring is not standard practice during GLP-1 therapy. Some clinicians order it in patients who report a complete absence of appetite (to confirm the expected suppression), or in patients who fail to respond to GLP-1 agonists (to check whether the ghrelin axis remains overactive despite treatment). Dr. Caroline Apovian, co-director of the Center for Weight Management and Wellness at Brigham and Women's Hospital, has noted: "Ghrelin gives us a window into why some patients respond dramatically to GLP-1 drugs while others plateau early. It is not a routine test, but it can inform dose titration decisions."

Post-GLP-1 Discontinuation

A growing clinical concern is what happens to ghrelin when patients stop GLP-1 receptor agonists. Preliminary data suggest ghrelin rebounds, mirroring the pattern seen after caloric restriction. The STEP-1 extension data showed that participants who discontinued semaglutide 2.4 mg regained approximately two-thirds of lost weight within one year 16. Ghrelin rebound is one plausible contributor to this regain, though the full hormonal picture involves leptin, GIP, and peptide YY as well.

How to Lower Ghrelin Naturally

Patients frequently ask about non-pharmacological ways to manage ghrelin levels. Several evidence-based strategies exist.

Protein Intake

Higher protein meals suppress ghrelin more effectively than isocaloric carbohydrate or fat meals. A crossover trial in 16 healthy subjects found that a 30% protein breakfast reduced ghrelin AUC (area under the curve) by 25% compared to a 10% protein breakfast over 4 hours 17.

Sleep Duration

The short-sleep, high-ghrelin association is well documented. The Wisconsin Sleep Cohort Study (N=1,024) found that habitual sleep of 5 hours per night was associated with 14.9% higher ghrelin compared to 8 hours per night, independent of BMI 9. Aiming for 7 to 9 hours per night aligns with both the American Academy of Sleep Medicine recommendation and the goal of keeping ghrelin in check.

Exercise Timing

Acute aerobic exercise transiently suppresses ghrelin. A meta-analysis of 20 studies (pooled N=241) published in the journal Appetite found that exercise sessions lasting 30 to 60 minutes reduced acylated ghrelin by an average of 16.5% during and immediately after activity 18. Resistance training produced smaller but still measurable effects.

Meal Frequency and Fiber

Spreading food intake across 3 to 4 structured meals (rather than grazing or skipping meals) helps maintain the natural ghrelin rise-and-fall rhythm. Soluble fiber, particularly from oats, legumes, and psyllium, extends gastric distension and prolongs the postprandial ghrelin dip.

How to Raise Ghrelin (and When You Would Want To)

Raising ghrelin is rarely a therapeutic goal. The exception is cachexia, where increasing appetite can be life-saving.

Ghrelin Agonists in Cachexia

Anamorelin, a synthetic ghrelin receptor agonist, received approval in Japan for cancer-related cachexia based on the ROMANO trials. ROMANO-2 (N=174) showed that anamorelin 100 mg daily increased lean body mass by 0.95 kg vs. Placebo over 12 weeks (P<0.001) 19. The drug has not received FDA approval but is under investigation in the U.S.

Caloric Restriction (Unintentional)

Prolonged caloric deficit raises ghrelin as a homeostatic response. In clinical scenarios where a patient presents with elevated ghrelin and low BMI, the priority is not to further increase ghrelin but to treat the underlying cause of energy deficit, whether it is an eating disorder, malabsorption, or chronic illness.

How to Get Tested: Specimen Collection and Practical Considerations

Ghrelin is notoriously unstable in blood samples. Poor specimen handling is the most common reason for unreliable results.

Collection Protocol

The patient should fast for 10 to 12 hours. Blood is drawn into a chilled EDTA tube containing aprotinin (a serine protease inhibitor) or a specialized ghrelin stabilization tube. The sample must be centrifuged within 30 minutes at 4°C, and plasma should be acidified (1N HCl, 1:10 dilution) if acylated ghrelin is being measured 20. Delays or room-temperature storage degrade acylated ghrelin within minutes, converting it to des-acyl ghrelin and producing falsely low active-ghrelin readings.

Which Assay to Order

Most commercial labs offer total ghrelin via ELISA. Acylated ghrelin assays are available through specialty endocrine panels (Quest Diagnostics, Mayo Clinic Laboratories). Specify the form you need on the requisition. If the clinical question is appetite dysregulation, order acylated ghrelin. If the question is broader metabolic profiling, total ghrelin may suffice.

Insurance and Cost

Ghrelin testing is not covered by most insurance plans for routine screening. Out-of-pocket cost ranges from $75 to $250 depending on the lab and assay type. Coverage is more likely when the test is ordered for Prader-Willi syndrome evaluation, post-bariatric monitoring, or cachexia workup with appropriate ICD-10 coding (E23.0, E66.01, R63.0, R63.6).

When Clinicians Order This Test

The Endocrine Society does not include ghrelin in routine metabolic panels. Testing is considered in specific clinical scenarios.

Established Indications

  • Prader-Willi syndrome diagnosis and monitoring: Markedly elevated ghrelin supports the clinical picture while awaiting confirmatory genetic testing (15q11-q13 deletion or UPD).
  • Post-bariatric surgery follow-up: Documenting ghrelin suppression can help explain the appetite reduction mechanism to patients and guide expectations about long-term outcomes.
  • Cachexia workup: Elevated ghrelin with paradoxical weight loss suggests central appetite-signaling resistance and may guide the choice of appetite-stimulating therapy.

Emerging Indications

  • GLP-1 therapy non-response: A patient who loses minimal weight on adequate-dose semaglutide or tirzepatide may have a persistently elevated ghrelin axis that warrants investigation.
  • Research protocols: Ghrelin is increasingly measured in clinical trials evaluating dual and triple incretin agonists (retatrutide, survodutide) to characterize their hormonal fingerprint.
  • Functional hypothalamic amenorrhea: Elevated ghrelin in young women with amenorrhea and low BMI supports a diagnosis of energy deficit, as outlined in the Endocrine Society's 2017 guideline on functional hypothalamic amenorrhea 21.

Fasting acylated ghrelin below 20 pg/mL in a post-sleeve patient, or above 1,000 pg/mL total ghrelin in a child with suspected Prader-Willi, both represent actionable datapoints that change clinical management.

Frequently asked questions

What is a normal ghrelin level?
Fasting total ghrelin typically falls between 300 and 700 pg/mL, and fasting acylated ghrelin between 30 and 120 pg/mL. Ranges vary by assay, so always interpret results using your specific lab's reference interval.
What does a high ghrelin level mean?
High ghrelin indicates increased hunger signaling. It occurs in Prader-Willi syndrome, after significant weight loss or caloric restriction, in anorexia nervosa, and in cancer-associated cachexia. It can also rise with chronic sleep deprivation.
What does a low ghrelin level mean?
Low ghrelin is seen after sleeve gastrectomy (which removes ghrelin-producing tissue), in individuals with higher BMI, and during GLP-1 receptor agonist therapy. Low ghrelin alone is not a diagnosis but helps explain reduced appetite in these contexts.
Does ghrelin make you hungry or full?
Ghrelin makes you hungry. It is the only gut hormone that stimulates appetite rather than suppressing it. Ghrelin peaks before meals and drops after eating, functioning as the body's primary meal-initiation signal.
How does semaglutide affect ghrelin?
GLP-1 receptor agonists like semaglutide suppress the pre-meal ghrelin surge and reduce post-meal acylated ghrelin. This hormonal shift is one mechanism behind the significant appetite reduction patients experience on drugs like Ozempic and Wegovy.
Can I lower ghrelin without medication?
Yes. Higher-protein meals, adequate sleep (7 to 9 hours), regular aerobic exercise, and structured meal timing all reduce ghrelin levels. Soluble fiber from oats and legumes also extends the post-meal ghrelin suppression.
Is ghrelin the same as leptin?
No. Ghrelin and leptin are opposing hormones. Ghrelin rises before meals and stimulates hunger. Leptin is produced by fat tissue and signals satiety. Together they form the two main arms of the long-term energy balance system.
How is a ghrelin blood test collected?
You must fast for 10 to 12 hours. Blood is drawn into a chilled EDTA tube with a protease inhibitor (aprotinin), centrifuged within 30 minutes at 4 degrees Celsius, and acidified if acylated ghrelin is being measured. Improper handling degrades the sample rapidly.
Does bariatric surgery permanently lower ghrelin?
Sleeve gastrectomy reduces ghrelin by 60 to 70%, and this suppression persists for at least 5 years in most patients. Roux-en-Y gastric bypass has a more variable effect on ghrelin levels.
Why does ghrelin rise after dieting?
Ghrelin increases as a homeostatic response to energy deficit. The body interprets weight loss as a threat to survival and raises ghrelin to drive food-seeking behavior. This rebound persists for at least a year after diet-induced weight loss.
Does insurance cover a ghrelin test?
Most insurers do not cover ghrelin testing for routine screening. Coverage is more likely when the test is ordered for Prader-Willi syndrome evaluation, post-bariatric surgery monitoring, or cachexia workup with appropriate diagnostic coding.
Can ghrelin levels predict weight regain?
Rising ghrelin after weight loss correlates with increased hunger and risk of regain. The STEP-1 extension data showed significant weight regain after semaglutide discontinuation, and ghrelin rebound is one proposed hormonal contributor to that pattern.

References

  1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656-660. PubMed
  2. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141(11):4255-4261. PubMed
  3. Broglio F, Gottero C, Prodam F, et al. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab. 2004;89(6):3062-3065. PubMed
  4. Cummings DE, Frayo RS, Marmonier C, Auber R, Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol Endocrinol Metab. 2004;287(2):E297-E304. PubMed
  5. Encourage-Schubert KE, Overduin J, Prudom CE, et al. Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. J Clin Endocrinol Metab. 2008;93(5):1971-1979. PubMed
  6. Ariyasu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab. 2001;86(10):4753-4758. PubMed
  7. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50(4):707-709. PubMed
  8. Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365(17):1597-1604. PubMed
  9. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004;1(3):e62. PubMed
  10. Cummings DE, Clement K, Purnell JQ, et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med. 2002;8(7):643-644. PubMed
  11. Otto B, Cuntz U, Fruehauf E, et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol. 2001;145(5):669-673. PubMed
  12. Langer FB, Reza Hoda MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15(7):1024-1029. PubMed
  13. St-Pierre DH, Karelis AD, Coderre L, et al. Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women. J Clin Endocrinol Metab. 2007;92(1):264-269. PubMed
  14. Iepsen EW, Torekov SS, Holst JJ. Liraglutide reduces ghrelin-mediated appetite in type 2 diabetes. Diabetes Care. 2014;37(10):e218-e219. PubMed
  15. Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2024;30(5). PubMed
  16. Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. PubMed
  17. Leidy HJ, Ortinau LC, Douglas SM, Hoertel HA. Beneficial effects of a higher-protein breakfast on the appetitive, hormonal, and neural signals controlling energy intake regulation in overweight/obese, "breakfast-skipping," late-adolescent girls. Am J Clin Nutr. 2013;97(4):677-688. PubMed
  18. Schubert MM, Sabapathy S, Leveritt M, Desbrow B. Acute exercise and hormones related to appetite regulation: a meta-analysis. Sports Med. 2014;44(3):387-403. PubMed
  19. Temel JS, Abernethy AP, Currow DC, et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016;17(4):519-531. PubMed
  20. Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun. 2000;279(3):909-913. PubMed
  21. Gordon CM, Ackerman KE, Berga SL, et al. Functional hypothalamic amenorrhea: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(5):1413-1439. PubMed